NPI: 1689638835 · RICHMOND, VA 23227 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 22,889 | $245K |
| 2019 | 19,429 | $279K |
| 2020 | 13,601 | $385K |
| 2021 | 12,989 | $285K |
| 2022 | 6,299 | $303K |
| 2023 | 5,036 | $354K |
| 2024 | 1,419 | $143K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 27,172 | 1,860 | $1.85M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 23,084 | 1,269 | $123K |
| J1270 | Injection, doxercalciferol, 1 mcg | 16,029 | 1,094 | $8K |
| J1756 | Injection, iron sucrose, 1 mg | 4,629 | 858 | $7K |
| A4657 | Syringe, with or without needle, each | 3,496 | 1,059 | $5K |
| 83970 | 1,401 | 677 | $136.31 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 102 | 37 | $129.33 |
| 82728 | 1,247 | 641 | $64.68 | |
| 90674 | 16 | 15 | $44.11 | |
| G0008 | Administration of influenza virus vaccine | 42 | 28 | $43.08 |
| 83540 | 1,203 | 636 | $30.72 | |
| 85041 | 954 | 518 | $25.82 | |
| 85048 | 934 | 511 | $24.62 | |
| 83550 | 1,204 | 634 | $21.31 | |
| 82108 | 149 | 82 | $0.77 |